Epilepsy medications will not be rationed in the event of a no-deal Brexit

11th March 2019

The deadline for Brexit is getting ever closer as the UK is set to leave the EU on 29th March 2019. However, many things are still up in the air and the manner of the departure is still unclear. One option is a “no deal Brexit”, which many experts feel will have a big impact…

Read more

Category: Treatments

Emergency medication for the prevention of status epilepticus in the community

25th February 2019

More often than not, a person’s seizure will last for a similar amount of time and stop by itself. However, sometimes a seizure will last longer than 5 minutes or another seizure will occur straight after leaving the person with no time to recover. If this lasts for 30 minutes or more, a diagnosis of…

Read more

Category: Treatments

Medication and side effects for simple partial seizures

26th October 2018

As we have explained in other posts, a simple partial seizure takes place in only one side of the brain. Those who experience simple partial seizures do not lose consciousness or awareness. Anti-epileptic drugs (AEDs), also known as anti-convulsants, are what will be prescribed to treat simple partial seizures. We’re going to take a closer…

Read more

Category: Treatments

Cannabis-based medicines to be made available on prescription from November 1st

16th October 2018

In an announcement made on the 11th of October 2018, the Home Office has formalised the rescheduling of cannabis-based medicines, such as CBD oils. The announcement stated that cannabis-based medicines will be available on prescription from the 1st November from specialist clinicians. These medicines will be available to patients who are considered to have an…

Read more

Category: Treatments

Generic vs brand prescriptions – why brand is always best

23rd August 2018

There are often different variations of anti-epileptic drugs (AED), this is because different brands may have slight bioavailability variations. Branded medication Once a new medication is developed, only the company that developed it are allowed to produce it, this is known as being ‘on patent’. After the patent runs out (10 years) other companies are…

Read more

Category: Treatments

Medical cannabis to be legalised in the UK

29th July 2018

After declaring that there was evidence to suggest that some cannabis-based medicines can be beneficial for people with certain conditions, including epilepsy, the Advisory Council on the Misuse of Drugs (ACMD) has declared that they should be made available for prescription in the short term. As a result, it seems that the UK is set…

Read more

Category: Treatments